Literature DB >> 1596201

Vitamin B12 metabolism in multiple sclerosis.

E H Reynolds1, T Bottiglieri, M Laundy, R F Crellin, S G Kirker.   

Abstract

We have previously described 10 patients with multiple sclerosis (MS) and unusual vitamin B12 deficiency. We have therefore studied vitamin B12 metabolism in 29 consecutive cases of MS, 17 neurological controls, and 31 normal subjects. Patients with MS had significantly lower serum vitamin B12 levels and significantly higher unsaturated R-binder capacities than neurological and normal controls, and they were significantly macrocytic compared with normal controls. Nine patients with MS had serum vitamin B12 levels less than 147 pmol/L and, in the absence of anemia, this subgroup was significantly macrocytic and had significantly lower red blood cell folate levels than neurological and normal controls. Nine patients with MS had raised plasma unsaturated R-binder capacities, including three patients with very high values. There is a significant association between MS and disturbed vitamin B12 metabolism. Vitamin B12 deficiency should always be looked for in patients with MS. The cause of the vitamin B12 disorder and the nature of the overlap with MS deserve further investigation. Coexisting vitamin B12 deficiency might aggravate MS or impair recovery from MS.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1596201     DOI: 10.1001/archneur.1992.00530300089014

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  14 in total

Review 1.  Complementary and alternative medicine: is there a role in multiple sclerosis?

Authors:  Vijayshree Yadav; Dennis Bourdette
Journal:  Curr Neurol Neurosci Rep       Date:  2006-05       Impact factor: 5.081

Review 2.  Hemoglobins as new players in multiple sclerosis: metabolic and immune aspects.

Authors:  Meric A Altinoz; Emin M Ozcan; Bahri Ince; Sinan Guloksuz
Journal:  Metab Brain Dis       Date:  2016-05-28       Impact factor: 3.584

3.  Betaine restores epigenetic control and supports neuronal mitochondria in the cuprizone mouse model of multiple sclerosis.

Authors:  Naveen K Singhal; Sarah Sternbach; Sheila Fleming; Kholoud Alkhayer; John Shelestak; Daniela Popescu; Alyx Weaver; Robert Clements; Brandi Wasek; Teodoro Bottiglieri; Ernest J Freeman; Jennifer McDonough
Journal:  Epigenetics       Date:  2020-03-09       Impact factor: 4.528

4.  Current Complementary and Alternative Therapies for Multiple Sclerosis.

Authors:  Allen C. Bowling; Thomas M. Stewart
Journal:  Curr Treat Options Neurol       Date:  2003-01       Impact factor: 3.598

Review 5.  The clinical potential of ademetionine (S-adenosylmethionine) in neurological disorders.

Authors:  T Bottiglieri; K Hyland; E H Reynolds
Journal:  Drugs       Date:  1994-08       Impact factor: 9.546

Review 6.  A Clinical Approach to the Differential Diagnosis of Multiple Sclerosis.

Authors:  Michel Toledano; Brian G Weinshenker; Andrew J Solomon
Journal:  Curr Neurol Neurosci Rep       Date:  2015-08       Impact factor: 6.030

7.  Vitamin B(12) Deficiency and Multiple Sclerosis; Is there Any Association?

Authors:  Mohamad Reza Najafi; Vahid Shaygannajad; Maryam Mirpourian; Ali Gholamrezaei
Journal:  Int J Prev Med       Date:  2012-04

8.  Dietary pattern and risk of multiple sclerosis.

Authors:  Soodeh Razeghi Jahromi; Mansoureh Toghae; Mohammad Jamal Razeghi Jahromi; Mahdi Aloosh
Journal:  Iran J Neurol       Date:  2012

9.  Changes in Methionine Metabolism and Histone H3 Trimethylation Are Linked to Mitochondrial Defects in Multiple Sclerosis.

Authors:  Naveen Kumar Singhal; Shuo Li; Erland Arning; Kholoud Alkhayer; Robert Clements; Zachary Sarcyk; Rohan S Dassanayake; Nicola E Brasch; Ernest J Freeman; Teodoro Bottiglieri; Jennifer McDonough
Journal:  J Neurosci       Date:  2015-11-11       Impact factor: 6.167

10.  Increased plasma homocysteine levels in patients with multiple sclerosis and depression.

Authors:  Nikolaos Triantafyllou; Maria-Eleftheria Evangelopoulos; Vasilios K Kimiskidis; Evangelia Kararizou; Fotini Boufidou; Konstantinos N Fountoulakis; Melina Siamouli; Chrysoula Nikolaou; Constantinos Sfagos; Nikolaos Vlaikidis; Dimitrios Vassilopoulos
Journal:  Ann Gen Psychiatry       Date:  2008-09-09       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.